PB Fintech Limited (BOM:543390)
India · Delayed Price · Currency is INR 1,034.50
+54.50 (5.56%)
At close: Oct 6, 2026
PB Fintech Market Cap
PB Fintech has a market cap or net worth of 478.84 billion as of October 7, 2026. Its market cap has decreased by -39.58% in one year.
Market Cap
478.84B
Enterprise Value
456.99B
Revenue
73.34B
Ranking
n/a
PE Ratio
64.00
Stock Price
1,034.50
ChartMarket Cap Chart
Since November 15, 2021, PB Fintech's market cap has decreased from 513.34B to 478.84B, a decrease of -6.72%. That is a compound annual growth rate of -1.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 481.20B | -43.03% |
| Dec 31, 2025 | 844.66B | -12.28% |
| Dec 31, 2024 | 962.86B | 170.91% |
| Dec 29, 2023 | 355.41B | 80.30% |
| Dec 30, 2022 | 197.13B | -51.42% |
| Dec 31, 2021 | 405.74B | -20.96% |
| Nov 15, 2021 | 513.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Berger Paints India | 541.08B |
| Linde India | 524.85B |
| Sterlite Technologies | 524.08B |
| Colgate-Palmolive (India) | 478.69B |
| Authum Investment & Infrastructure | 466.95B |
| Hindustan Copper | 464.12B |
| Cupid | 462.56B |
| GlaxoSmithKline Pharmaceuticals | 446.09B |